Strategies targeting endoplasmic reticulum stress to improve Parkinson's disease

Front Pharmacol. 2023 Nov 10:14:1288894. doi: 10.3389/fphar.2023.1288894. eCollection 2023.

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder with motor symptoms, which is caused by the progressive death of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). Accumulating evidence shows that endoplasmic reticulum (ER) stress occurring in the SNpc DA neurons is an early event in the development of PD. ER stress triggers the activation of unfolded protein response (UPR) to reduce stress and restore ER function. However, excessive and continuous ER stress and UPR exacerbate the risk of DA neuron death through crosstalk with other PD events. Thus, ER stress is considered a promising therapeutic target for the treatment of PD. Various strategies targeting ER stress through the modulation of UPR signaling, the increase of ER's protein folding ability, and the enhancement of protein degradation are developed to alleviate neuronal death in PD models. In this review, we summarize the pathological role of ER stress in PD and update the strategies targeting ER stress to improve ER protein homeostasis and PD-related events.

Keywords: ER stress; Parkinson’s disease; dopaminergic neurons; protein homeostasis; unfolded protein response.

Publication types

  • Review

Grants and funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the grants from The Science and Technology Development Fund, Macau SAR (File No. 0029/2021/ITP and SKL-QRCM(UM)-2023-2025), the Research Fund of University of Macau (File No. SRG 2020-00043-ICMS), the National Natural Science Foundation of China (No. 82204482), the Guangdong Basic and Applied Basic Research Foundation (China) (No. 2021A1515012520), Young Elite Scientists Sponsorship Program by CACM (China) (No. 2021-QNRC2-B22), Guangzhou Basic and Applied Basic Research Foundation (China) (No. 2023A03J0616), Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province (2022SXHD0003).